IChemE Honorary Fellowship given to EU parliament president
In recognition of his contribution to the process industries
IChemE Honorary Fellowships are reserved for distinguished individuals from the chemical and process industries who have made significant contributions to the field. An Honorary Fellowship is the most senior award bestowed by the Institution.
Richard Darton, IChemE past president and current president of the European Federation of Chemical Engineering (EFCE) presented Buzek with his certificate.
Buzek graduated from the mechanics and energy division of the Silesian University of Technology in Gliwice, Poland in 1963 before becoming a scientist in the chemical engineering institute of the Polish academy of sciences. He is also an honorary doctor of the universities in Seoul, South Korea and Dortmund, Germany.
Buzek is the author of approximately 200 research papers and has lectured at the Technical Universities of Silesia and Opole, Poland. He was also a co-founder of the Polish-German science network for energy and environment protection and founded the consortium for atmosphere protection in Silesia.
Buzek was founder of the Polonia School of Diplomacy and between 2002 and 2004 he was vice-rector of Polonia University. He served as prime minister of Poland from 1997–2001. Since 2004 he has been a member of the European Parliament.
Accepting the fellowship certificate, Buzek called for a better synergy between industry, academia and public authorities and said chemical engineers are leaders in the pursuit of solutions to major global challenges.
‘Everything is connected to the basic possibilities and science of chemical engineering, I am convinced that solutions to the challenges facing Europe will be found through research and applied innovation,’ he said.
IChemE ceo David Brown said he would echo Buzek’s call for more engineers and scientists to step forward into public life.
‘Society would be well served if they did so, as Jerzy Buzek has. It's great to have him as an Honorary Fellow of IChemE,’ he said.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing
Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
Research & Development
Veraxa and Secarna Pharmaceuticals partner to advance AOC therapies for immune diseases
The pair will develop next-generation antibody oligonucleotide conjugates (AOCs) with the aim of unlocking novel targeted therapies for the treatment of autoimmune and chronic immune diseases